/tags/moderna Moderna en-US WLRN Wed, 31 Aug 2022 14:37:29 GMT /news/2022-08-31/u-s-clears-updated-covid-boosters-targeting-newest-variants The U.S. Food and Drug Administration authorized on Wednesday an updated formula of the COVID-19 vaccine made by Pfizer and rival Moderna, which target today’s most common omicron strain. Wed, 31 Aug 2022 14:37:29 GMT /news/2022-08-31/u-s-clears-updated-covid-boosters-targeting-newest-variants Lauran Neergaard/Associated Press /local-news/2022-06-15/florida-surgeon-general-opposes-covid-19-shots-for-young-children As the Food and Drug Administration weighs approval of COVID-19 vaccinations for children under age 5, Florida Surgeon General Joseph Ladapo is opposed to the potential change. Wed, 15 Jun 2022 14:19:11 GMT /local-news/2022-06-15/florida-surgeon-general-opposes-covid-19-shots-for-young-children News Service of Florida /news/2022-06-08/moderna-says-its-new-vaccine-booster-shows-superior-response-to-omicron The "bivalent" vaccine — meaning it targets two different antigens — is Moderna's leading candidate to have an effective booster ready for fall of 2022, the company said. Wed, 08 Jun 2022 15:05:40 GMT /news/2022-06-08/moderna-says-its-new-vaccine-booster-shows-superior-response-to-omicron Bill Chappell /news/2022-04-28/moderna-asks-fda-to-authorize-first-covid-19-vaccine-for-very-young-children The company says a low-dose version of its vaccine triggers an immune response in children ages 6 months to less than 6 years equivalent to what has protected older children and adults. Thu, 28 Apr 2022 12:04:18 GMT /news/2022-04-28/moderna-asks-fda-to-authorize-first-covid-19-vaccine-for-very-young-children Rob Stein /2022-03-30/do-i-really-need-another-booster-the-answer-depends-on-age-risk-and-timing Health officials argue the protection of the COVID vaccine booster wanes over time and say some people need a second booster. But other infectious disease experts say three shots are enough for now. Wed, 30 Mar 2022 09:00:20 GMT /2022-03-30/do-i-really-need-another-booster-the-answer-depends-on-age-risk-and-timing Maria Godoy, Allison Aubrey, Jane Greenhalgh /2022-03-23/moderna-wants-the-fda-to-authorize-its-covid-19-vaccine-for-kids-under-6 No deaths were reported in tests, and there were no signs of myocarditis, or heart inflammation, as a side effect. Wed, 23 Mar 2022 13:37:21 GMT /2022-03-23/moderna-wants-the-fda-to-authorize-its-covid-19-vaccine-for-kids-under-6 Ayana Archie /2022-03-18/moderna-seeks-approval-for-a-2nd-covid-19-booster-shot-for-adults If approved, this would be the second booster shot Moderna has issued for people ages 18 and up. Fri, 18 Mar 2022 09:41:59 GMT /2022-03-18/moderna-seeks-approval-for-a-2nd-covid-19-booster-shot-for-adults Ayana Archie /2022-02-25/looks-like-non-mrna-vaccines-can-be-as-good-as-pfizer-and-moderna-in-certain-scenarios The consensus has been that Pfizer and Moderna are most protective. But a study looking at 5 vaccines — including Russia's Sputnik V and two Chinese types — offers an unexpected finding. Fri, 25 Feb 2022 15:27:51 GMT /2022-02-25/looks-like-non-mrna-vaccines-can-be-as-good-as-pfizer-and-moderna-in-certain-scenarios Charles Schmidt /2022-02-22/who-might-benefit-from-a-4th-shot-and-who-might-not Some countries are moving ahead with plans to offer a fourth dose of COVID-19 vaccine. But studies are raising questions about the potential advantages of this extra booster. Wed, 23 Feb 2022 12:06:29 GMT /2022-02-22/who-might-benefit-from-a-4th-shot-and-who-might-not Michaeleen Doucleff /2022-01-25/pfizer-and-biontech-begin-testing-an-omicron-specific-covid-19-vaccine Though people who are vaccinated and boosted appear to be better protected against omicron, the highly contagious variant has still led to breakthrough cases and a surge in infections worldwide. Tue, 25 Jan 2022 15:45:51 GMT /2022-01-25/pfizer-and-biontech-begin-testing-an-omicron-specific-covid-19-vaccine Joe Hernandez